Moat Biotechnology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $26.4K

  • Investors
  • 2

Moat Biotechnology General Information

Description

Developer of oral and intranasal vaccines designed to prevent infectious diseases. The company develops vaccines using a second-generation single-cycle adenovirus platform that stimulates mucosal and systemic immune responses, enabling pharmaceutical companies and vaccine developers to advance vaccine candidates targeting viral and infectious diseases.

Contact Information

Formerly Known As
MOAT Vaccine Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 840 Research Parkway
  • Suite 516
  • Oklahoma City, OK 73104
  • United States
+1 (405)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 840 Research Parkway
  • Suite 516
  • Oklahoma City, OK 73104
  • United States
+1 (405)

Moat Biotechnology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Moat Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 20-Oct-2025 $26.4K Completed Clinical Trials - Phase 1
4. Later Stage VC (Series C) 28-Dec-2023 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 01-Sep-2022 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 12-Jul-2022 $150K $150K Completed Clinical Trials - Phase 1
1. Spin-Off Completed Startup
To view Moat Biotechnology’s complete valuation and funding history, request access »

Moat Biotechnology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 7,004,000 $0.001000 $0 $0.02 $0.02 1x $0.02 28.64%
To view Moat Biotechnology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Moat Biotechnology Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Moat Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025196724-A1 Methods for inducing immune responses Pending 21-Mar-2024
AU-2023347247-A1 Methods and materials for using adenovirus vectors to immunize mammals Pending 19-Sep-2022
EP-4590835-A1 Methods and materials for using adenovirus vectors to immunize mammals Pending 19-Sep-2022
US-20260335430-A1 Methods and materials for using adenovirus vectors to immunize mammals Pending 19-Sep-2022
WO-2024064140-A1 Methods and materials for using adenovirus vectors to immunize mammals Inactive 19-Sep-2022 A61K39/215
To view Moat Biotechnology’s complete patent history, request access »

Moat Biotechnology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boyd Street Ventures Venture Capital Minority
Cortado Ventures Venture Capital Minority
To view Moat Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Moat Biotechnology FAQs

  • When was Moat Biotechnology founded?

    Moat Biotechnology was founded in 2022.

  • Where is Moat Biotechnology headquartered?

    Moat Biotechnology is headquartered in Oklahoma City, OK.

  • What industry is Moat Biotechnology in?

    Moat Biotechnology’s primary industry is Drug Discovery.

  • Is Moat Biotechnology a private or public company?

    Moat Biotechnology is a Private company.

  • What is Moat Biotechnology’s current revenue?

    The current revenue for Moat Biotechnology is .

  • How much funding has Moat Biotechnology raised over time?

    Moat Biotechnology has raised $8.18M.

  • Who are Moat Biotechnology’s investors?

    Boyd Street Ventures and Cortado Ventures have invested in Moat Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process